Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 13, 2026
Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions
Jerome Lian, Ricky R Lareu, Mohan Patil, et al.
International Journal of Molecular Sciences
|
June 12, 2026
Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease
Jerome Lian, Mohan Patil, Ricky R Lareu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 10, 2024
G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?
Mohan Patil, Ilaria Casari, Leon N Warne, et al.
Peptides
|
March 10, 2020
Glucagon-based therapy: Past, present and future
Mohan Patil, Nitin J Deshmukh, Mahesh Patel, et al.
Cells
|
December 17, 2024
Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic Innovations
Dinesh Thapa, Mohan Patil, Leon N Warne, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2025
Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011
Dinesh Thapa, Mohan Patil, Leon N Warne, et al.
International Journal of Molecular Sciences
|
August 28, 2025
Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis
Dinesh Thapa, Mohan Patil, Leon N Warne, et al.
Bioscience Reports
|
June 17, 2026
The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies
Marco Falasca, Mohan Patil, Federico Piccinini, et al.
Drug Research
|
April 14, 2025
Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without Diabetes
Nitin J Deshmukh, M S Kalshetti, Mohan Patil, et al.
Clinical and Experimental Pharmacology & Physiology
|
March 25, 2024
Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon-like peptide 1
Nitin J Deshmukh, M S Kalshetti, Mohan Patil, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 13, 2026
Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions
Jerome Lian, Ricky R Lareu, Mohan Patil, et al.
International Journal of Molecular Sciences
|
June 12, 2026
Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease
Jerome Lian, Mohan Patil, Ricky R Lareu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 10, 2024
G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?
Mohan Patil, Ilaria Casari, Leon N Warne, et al.
Peptides
|
March 10, 2020
Glucagon-based therapy: Past, present and future
Mohan Patil, Nitin J Deshmukh, Mahesh Patel, et al.
Cells
|
December 17, 2024
Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic Innovations
Dinesh Thapa, Mohan Patil, Leon N Warne, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2025
Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011
Dinesh Thapa, Mohan Patil, Leon N Warne, et al.
International Journal of Molecular Sciences
|
August 28, 2025
Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis
Dinesh Thapa, Mohan Patil, Leon N Warne, et al.
Bioscience Reports
|
June 17, 2026
The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies
Marco Falasca, Mohan Patil, Federico Piccinini, et al.
Drug Research
|
April 14, 2025
Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without Diabetes
Nitin J Deshmukh, M S Kalshetti, Mohan Patil, et al.
Clinical and Experimental Pharmacology & Physiology
|
March 25, 2024
Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon-like peptide 1
Nitin J Deshmukh, M S Kalshetti, Mohan Patil, et al.
Page
of 2